Payments to Acquire Property, Plant, and Equipment of Evofem Biosciences, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Evofem Biosciences, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Evofem Biosciences, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $14,000, a 367% increase year-over-year.
  • Evofem Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $5,000, a 64% decline from 2024.
  • Evofem Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $14,000, a 250% increase from 2023.
  • Evofem Biosciences, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $4,000, a 99% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Evofem Biosciences, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,000 -$9,000 -64% 01 Jan 2025 31 Dec 2025 10-K 11 Mar 2026 2025 FY
2024 $14,000 +$10,000 +250% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2026 2025 FY
2023 $4,000 -$337,000 -99% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $341,000 -$2,598,000 -88% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $2,939,000 +$685,000 +30% 01 Jan 2021 31 Dec 2021 10-K 27 Apr 2023 2022 FY
2020 $2,254,000 +$2,090,000 +1274% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $164,000 +$157,000 +2243% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
2018 $7,000 +$1,000 +17% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $6,000 -$492,000 -99% 01 Jan 2017 31 Dec 2017 10-K 01 Mar 2019 2018 FY
2016 $498,000 +$271,872 +120% 01 Jan 2016 31 Dec 2016 8-K/A 06 Apr 2018
2015 $226,128 +$208,050 +1151% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018 2017 FY
2014 $18,078 -$3,079 -15% 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2017 2016 FY
2013 $21,157 01 Jan 2013 31 Dec 2013 10-K 29 Mar 2016 2015 FY

Evofem Biosciences, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $14,000 +$11,000 +367% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $3,000 -$63,000 -95% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $66,000 -$890,000 -93% 01 Jan 2022 31 Mar 2022 10-Q 16 Jun 2023 2023 Q1
Q1 2021 $956,000 +$861,000 +906% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $95,000 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2015 $226,128 +$223,510 +8537% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $2,618 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.